A University of Central Florida research team has identified a gene called MCPIP (Monocyte Chemotactic Protein-1 Induced Protein) that controls the development of fat cells.

MCPIP could be an ideal target for drugs that can shut down its function to prevent obesity and the major inflammatory diseases resulting it, including diabetes and cardiovascular diseases.